Theravance Biopharma, Inc. · NASDAQ:TBPH
Farnum Rhonda sold 13,314 Theravance Biopharma, Inc. shares (Form 4)
Traded Sep 15, 2026 · Filed Sep 17, 2026
On Sep 15, 2026, Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) sold 13,314 Theravance Biopharma, Inc. shares at US$17.03 for US$227K under a trading plan, leaving 213,476 shares. Filed Sep 17, 2026 (Form 4).
- Sold
- 13,314 shares
- Price
- US$17.03
- Value
- US$227K
- Holding after
- 213,476 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, COMM & MEDICAL AFFAIRS
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Ordinary Shares | Sale | 3,329 | US$17.03 | 223,461 | Direct |
| Sep 15, 2026 | Ordinary Shares | Sale | 3,328 | US$17.03 | 220,133 | Direct |
| Sep 15, 2026 | Ordinary Shares | Sale | 6,657 | US$17.03 | 213,476 | Direct |
Source
Related
- Theravance Biopharma, Inc.
- Farnum Rhonda
- Theravance Biopharma, Inc. shareholders
- Form 4 · Farnum Rhonda · Sep 24, 2026
- Form 4 · Farnum Rhonda · Aug 24, 2026
- Form 4 · Farnum Rhonda · Jun 17, 2026
- Form 4 · Farnum Rhonda · May 22, 2026
- Form 4 · Farnum Rhonda · Apr 3, 2026
- Form 4 · Weiss Asset Management LP · Sep 28, 2026
- Schedule 13D/A · Weiss Asset Management LP · Sep 25, 2026
- Form 4 · Pakianathan Deepika · Sep 24, 2026
- Form 4 · O'Connor Donal · Sep 24, 2026
- Form 4 · Mitchell Dean J · Sep 24, 2026